{
  "DOI": "10.1007/s10689-017-0047-1",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-017-0047-1",
  "alternative-id": [
    "47"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kearton",
      "given": "Stephanie",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Wills",
      "given": "Karen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bunting",
      "given": "Michael",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Blomfield",
      "given": "Penny",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "James",
      "given": "Paul A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Burke",
      "given": "Jo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        10,
        16
      ]
    ],
    "date-time": "2017-10-16T04:20:58Z",
    "timestamp": 1508127658000
  },
  "deposited": {
    "date-parts": [
      [
        2018,
        6,
        13
      ]
    ],
    "date-time": "2018-06-13T07:31:28Z",
    "timestamp": 1528875088000
  },
  "funder": [
    {
      "DOI": "10.13039/100012503",
      "doi-asserted-by": "crossref",
      "name": "Royal Hobart Hospital Research Foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        16
      ]
    ],
    "date-time": "2023-09-16T04:56:06Z",
    "timestamp": 1694840166413
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2017,
        10,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2018,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            10,
            16
          ]
        ],
        "date-time": "2017-10-16T00:00:00Z",
        "timestamp": 1508112000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-017-0047-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0047-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0047-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "333-344",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        10,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        10,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "crossref",
      "first-page": "1329",
      "issue": "11",
      "journal-title": "J Clin Oncol",
      "key": "47_CR1",
      "unstructured": "Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329–1333",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "47_CR2",
      "unstructured": "Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.ygyno.2015.10.001",
      "author": "R Manchanda",
      "doi-asserted-by": "crossref",
      "first-page": "487",
      "issue": "3",
      "journal-title": "Gynaecol Oncol",
      "key": "47_CR3",
      "unstructured": "Manchanda R, Legood R, Pearce L, Menon U (2015) Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk post-menopausal women. Gynaecol Oncol 139(3):487–494",
      "volume": "139",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jama.2010.1237",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "issue": "9",
      "journal-title": "JAMA",
      "key": "47_CR4",
      "unstructured": "Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t’veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–969",
      "volume": "304",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMsr1501341",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "2243",
      "journal-title": "N Engl J Med",
      "key": "47_CR5",
      "unstructured": "Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast cancer risk. N Engl J Med 372:2243–2257",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1055",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "47_CR6",
      "unstructured": "Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van’t Veer L, Garber JE, Evans G, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22(6):1055–1062",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03258-X",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1876",
      "journal-title": "The Lancet",
      "key": "47_CR7",
      "unstructured": "Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H, Hereditary Breast Cancer Clinical Study Group (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. The Lancet 356:1876–1881",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.1001/jama.286.18.2251",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "2251",
      "issue": "18",
      "journal-title": "JAMA",
      "key": "47_CR8",
      "unstructured": "King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B, National Surgical Adjuvant Breast and Bowel Project (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) breast cancer prevention trial. JAMA 286(18):2251–2256",
      "volume": "286",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2004.04.033",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "2328",
      "issue": "12",
      "journal-title": "J Clin Oncol",
      "key": "47_CR9",
      "unstructured": "Metcalfe KA, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2012.47.8313",
      "author": "KA Phillips",
      "doi-asserted-by": "crossref",
      "first-page": "3091",
      "issue": "25",
      "journal-title": "J Clin Oncol",
      "key": "47_CR10",
      "unstructured": "Phillips KA, Milne R, Rookus MA, Daly MB, Antoniou AC, Peock S, Frost D, Easton DF, Ellis S, Friedlander ML, Buys SS, Andrieu N, Noguès C, Stoppa-Lyonnet D, Bonadona V, Pujol P, McLachlan SA, John EM, Hooning MJ, Seynaeve C, Tollenaar RA, Goldgar DE, Terry MB, Caldes T, Weideman PC, Andrulis IL, Singer CF, Birch K, Simard J, Southey MC, Olsson HL, Jakubowska A, Olah E, Gerdes AM, Foretova L, Hopper JL (2013) Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J Clin Oncol 31(25):3091–3099",
      "volume": "31",
      "year": "2013"
    },
    {
      "key": "47_CR11",
      "unstructured": "eviQ Cancer Treatments Online (2016) Risk Management for a Female BRCA1 Mutation Carrier V.5. Cancer Institute NSW, \nhttps://www.eviq.org.au/Protocol/tabid/66/categoryid/66/id/170/Risk+Management+for+a+Female+BRCA1+Mutation+Carrier.aspx\n\n Accessed 28 May 2017"
    },
    {
      "key": "47_CR12",
      "unstructured": "eviQ Cancer Treatments Online (2016) Risk Management for a Female BRCA2 Mutation Carrier V.4. Cancer Institute NSW\nhttps://www.eviq.org.au/Protocol/tabid/66/categoryid/66/id/162/Risk+Management+for+an+Unaffected+Female+BRCA2+Mutation+Carrier.aspx\n\n, Accessed 28 May 2017"
    },
    {
      "DOI": "10.1111/j.1471-0528.2007.01499.x",
      "author": "ER Woodward",
      "doi-asserted-by": "crossref",
      "first-page": "1500",
      "journal-title": "BJOG",
      "key": "47_CR13",
      "unstructured": "Woodward ER, Sleightholme HV, Considine AM, Williamson S, McHugo JM, Cruger DG (2007) Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG 114:1500–1509",
      "volume": "114",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6603725",
      "author": "BB Hermsen",
      "doi-asserted-by": "crossref",
      "first-page": "1335",
      "issue": "9",
      "journal-title": "Br J Cancer",
      "key": "47_CR14",
      "unstructured": "Hermsen BB, Olivier RI, Verheijen RH, van Beurden M, de Hullu JA, Massuger LF, Burger CW, Brekelmans CT, Mourits MJ, de Bock GH, Gaarenstroom KN, van Boven HH, Mooij TM, Rookus MA (2007) No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. Br J Cancer 96(9):1335–1342",
      "volume": "96",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmg.2008.058248",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "593",
      "issue": "9",
      "journal-title": "Med Genet",
      "key": "47_CR15",
      "unstructured": "Evans DG, Gaarenstrooom KN, Stirling D, Shenton A, Maehle L, Dørum A, Steel M, Lalloo F, Apold J, Porteous ME, Vasen HF, van Asperen CJ, Moller P (2009) Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers. J Med Genet 46(9):593–597",
      "volume": "46",
      "year": "2000"
    },
    {
      "DOI": "10.1006/pmed.2000.0684",
      "author": "C Lerman",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "issue": "1",
      "journal-title": "Prev Med",
      "key": "47_CR16",
      "unstructured": "Lerman C, Hughes C, Croyle RT, Main D, Durham C, Snyder C, Bonney A, Lynch JF, Narod SA, Lynch HT (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31(1):75–80",
      "volume": "31",
      "year": "2000"
    },
    {
      "DOI": "10.1111/j.1399-0004.2006.00665.x",
      "author": "KA Phillips",
      "doi-asserted-by": "crossref",
      "first-page": "198",
      "journal-title": "Clin Genet",
      "key": "47_CR17",
      "unstructured": "Phillips KA, Jenkins MA, Lindeman GJ, McLachlan SA, McKinley JM, Weideman PC, Hopper JL, Friedlander ML, kConFab Investigators (2006) Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet 70:198–206",
      "volume": "70",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2006.07.4922",
      "author": "JB Madalinska",
      "doi-asserted-by": "crossref",
      "first-page": "301",
      "issue": "3",
      "journal-title": "J Clin Oncol",
      "key": "47_CR18",
      "unstructured": "Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Lubsen-Brandsma L, Massuger LF, Mourits MJ, Gaarenstroom KN, van Dorst EB, van der Putten H, Boonstra H, Aaronson NK (2007) Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers. J Clin Oncol 25(3):301–307",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.3816/CBC.2007.n.053",
      "author": "TM Friebel",
      "doi-asserted-by": "crossref",
      "first-page": "875",
      "issue": "11",
      "journal-title": "Clin Breast Cancer",
      "key": "47_CR19",
      "unstructured": "Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR (2007) Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clin Breast Cancer 7(11):875–882",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ijc.23340",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "2017",
      "journal-title": "Int J Cancer",
      "key": "47_CR20",
      "unstructured": "Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122:2017–2022",
      "volume": "122",
      "year": "2008"
    },
    {
      "DOI": "10.1097/GIM.0b013e318163487d",
      "author": "AR Bradbury",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "issue": "3",
      "journal-title": "Genet Med",
      "key": "47_CR21",
      "unstructured": "Bradbury AR, Ibe CN, Dignam JJ, Cummings SA, Verp M, White MA, Artioli G, Dudlicek L, Olopade OI (2008) Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med 10(3):161–166",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1089/gtmb.2008.0067",
      "author": "MS Beattie",
      "doi-asserted-by": "crossref",
      "first-page": "51",
      "issue": "1",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "47_CR22",
      "unstructured": "Beattie MS, Crawford B, Lin F, Vittinghoff E, Ziegler J (2009) Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomarkers 13(1):51–56",
      "volume": "13",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1399-0004.2009.01329.x",
      "author": "AB Skytte",
      "doi-asserted-by": "crossref",
      "first-page": "342",
      "journal-title": "Clin Genet",
      "key": "47_CR23",
      "unstructured": "Skytte AB, Gerdes AM, Andersen MK, Sunde L, Brøndum-Nielsen K, Waldstrøm M, Kølvraa S, Crüger D (2017) Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing. Clin Genet 77:342–349",
      "volume": "77",
      "year": "2017"
    },
    {
      "DOI": "10.1038/bjc.2011.573",
      "author": "L Sidon",
      "doi-asserted-by": "crossref",
      "first-page": "775",
      "issue": "4",
      "journal-title": "Br J Cancer",
      "key": "47_CR24",
      "unstructured": "Sidon L, Ingham S, Clancy T, Clayton R, Clarke A, Jones EA, Lalloo F, Evans DG (2012) Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women. Br J Cancer 106(4):775–779",
      "volume": "106",
      "year": "2012"
    },
    {
      "author": "IM Collins",
      "first-page": "680",
      "issue": "10",
      "journal-title": "MJA",
      "key": "47_CR25",
      "unstructured": "Collins IM, Milne RL, Weideman PC, McLachlan SA, Friedlander ML; Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer, Hopper JL, Phillips KA (2013) Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers. MJA 199(10):680–683",
      "volume": "199",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ygyno.2016.07.104",
      "author": "MG Harmsen",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "journal-title": "Gynecol Oncol",
      "key": "47_CR26",
      "unstructured": "Harmsen MG, Arts-de Jong M, Horstik K, Manders P, Massuger LFAG, Hermens RPMG, Hoogerbrugge N, Woldringh GH, de Hullu JA (2016) Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-centre experience. Gynecol Oncol 143:113–119",
      "volume": "143",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s00432-015-2051-x",
      "author": "SI Kim",
      "doi-asserted-by": "crossref",
      "first-page": "333",
      "issue": "1",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "47_CR27",
      "unstructured": "Kim SI, Lim MC, Lee DO, Kong SY, Seo SS, Kang S, Lee ES, Park SY (2016) Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea. J Cancer Res Clin Oncol 142(1):333–340",
      "volume": "142",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10897-016-9981-6",
      "author": "AH Buchanan",
      "doi-asserted-by": "crossref",
      "first-page": "79",
      "issue": "1",
      "journal-title": "J Genet Counsel",
      "key": "47_CR28",
      "unstructured": "Buchanan AH, Voils CI, Schildkraut JM, Fine C, Horick NK, Marcom PK, Wiggins K, Skinner CS (2017) Adherence to recommended risk management among unaffected women with a BRCA mutation. J Genet Counsel 26(1):79–92",
      "volume": "26",
      "year": "2017"
    },
    {
      "key": "47_CR29",
      "unstructured": "Australian Bureau of Statistics (2016) Regional Population Growth, Australia, 2014-15, cat no. 3218.0,, \nhttp://www.abs.gov.au/AUSSTATS/abs@.nsf/Latestproducts/3218.0Main%20Features452014-15?opendocument\u0026tabname=Summary\u0026prodno=3218.0\u0026issue=2014-15\u0026num=\u0026view=\n\n Accessed 8 March 2017"
    },
    {
      "key": "47_CR30",
      "unstructured": "Tasmanian Medicare Local (2014) Primary Health Indicators Tasmania Report, 6 (1) August 2014, accessed 28 May 2017 \nhttp://www.tasmedicarelocal.com.au"
    },
    {
      "author": "Australian Bureau of Statistics",
      "key": "47_CR31",
      "unstructured": "Australian Bureau of Statistics (2011) Socio-economic indexes for areas (SEIFA) technical paper. ABS Catalogue no. 2033.0.55.001. ABS, Canberra",
      "volume-title": "Socio-economic indexes for areas (SEIFA) technical paper. ABS Catalogue no. 2033.0.55.001",
      "year": "2011"
    },
    {
      "DOI": "10.1191/1478088706qp063oa",
      "author": "V Braun",
      "doi-asserted-by": "crossref",
      "first-page": "77",
      "issue": "2",
      "journal-title": "Qual Res Psychol",
      "key": "47_CR32",
      "unstructured": "Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-2953",
      "author": "SM Miller",
      "doi-asserted-by": "crossref",
      "first-page": "5094",
      "issue": "21",
      "journal-title": "Clin Cancer Res",
      "key": "47_CR33",
      "unstructured": "Miller SM, Roussi P, Daly MB, Scarpato J (2010) New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res 16(21):5094–5106",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-008-9189-5",
      "author": "JR Leeuw De",
      "doi-asserted-by": "crossref",
      "first-page": "347",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "47_CR34",
      "unstructured": "De Leeuw JR, van Vliet MJ, Ausems MG (2008) Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer. Fam Cancer 7(4):347–359",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10897-009-9245-9",
      "author": "AF Howard",
      "doi-asserted-by": "crossref",
      "first-page": "578",
      "issue": "6",
      "journal-title": "J Genet Couns",
      "key": "47_CR35",
      "unstructured": "Howard AF, Balneaves LG, Bottorff JL (2009) Women’s decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review. J Genet Couns 18(6):578–597",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.288.3.321",
      "author": "JE Rossouw",
      "doi-asserted-by": "crossref",
      "first-page": "321",
      "issue": "3",
      "journal-title": "JAMA",
      "key": "47_CR36",
      "unstructured": "Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333",
      "volume": "288",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.ctrv.2017.02.005",
      "author": "M Nourmoussavi",
      "doi-asserted-by": "crossref",
      "first-page": "26",
      "journal-title": "Cancer Treat Rev",
      "key": "47_CR37",
      "unstructured": "Nourmoussavi M, Pansegrau G, Popesku J, Hammond GL, Kwon JS, Carey MS (2017) Ovarian ablation for premenopausal breast cancer: a review of treatment considerations and the impact of premature menopause. Cancer Treat Rev 55:26–35",
      "volume": "55",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10689-011-9504-4",
      "author": "N Hallowell",
      "doi-asserted-by": "crossref",
      "first-page": "215",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "47_CR38",
      "unstructured": "Hallowell N, Baylock B, Heiniger L, Butow PN, Patel D, Meiser B, Saunders C; kConFab Psychosocial Group on behalf of the kConFab Investigators, Price MA (2012) Looking different, feeling different: women’s reactions to risk-reducing breast and ovarian surgery. Fam Cancer. 11(2):215–224",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-016-3685-3",
      "author": "J Kotsopoulos",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "47_CR39",
      "unstructured": "Kotsopoulos J, Huzarski T, Gronwald J, Moller P, Lynch HT, Neuhausen SL, Senter L, Demsky R, Foulkes WD, Eng C, Karlan B, Tung N, Singer CF, Sun P, Lubinski J, Narod SA (2016) Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study. Breast Cancer Res Treat 155(2):365–373",
      "volume": "155",
      "year": "2016"
    },
    {
      "DOI": "10.1097/COC.0000000000000269",
      "author": "N Birrer",
      "doi-asserted-by": "publisher",
      "journal-title": "Am J Clin Oncol",
      "key": "47_CR40",
      "unstructured": "Birrer N, Chinchilla C, Del Carmen M, Dizon DS (2016) Is hormone replacement therapy safe in women with a brca mutation?: a systematic review of the contemporary literature. Am J Clin Oncol. doi:\n10.1097/COC.0000000000000269",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMra1503523",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "454",
      "issue": "5",
      "journal-title": "N Engl J Med",
      "key": "47_CR41",
      "unstructured": "Hartmann LC, Lindor NM (2016) The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 374(5):454–468",
      "volume": "374",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jama.291.14.1775",
      "author": "GL Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "1701",
      "issue": "14",
      "journal-title": "JAMA",
      "key": "47_CR42",
      "unstructured": "Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O’Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women’s Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 291(14):1701–1712",
      "volume": "291",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.breast.2017.02.008",
      "author": "MG Schrauder",
      "doi-asserted-by": "crossref",
      "first-page": "186",
      "journal-title": "Breast",
      "key": "47_CR43",
      "unstructured": "Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Reis A, Schulz-Wendtland R, Beckmann MW, Lux MP (2017) Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer. Breast 32:186–191",
      "volume": "32",
      "year": "2017"
    }
  ],
  "reference-count": 43,
  "references-count": 43,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-017-0047-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}